Hyal Albendazole Tablets

Adult dose

Adults 1) Pinworm: Take 400 mg of albendazole once daily. To achieve eradication, take another 400 mg dose of this medicine once, 7 days later. 2) Ascaris, hookworm, whipworm, and American hookworm: Take a single 400 mg dose of this medicine. 3) Strongyloides with other parasites (tapeworms) and severe mixed infections: Take 400 mg of this medicine once daily for 3 days. If swallowing is difficult, the tablet may be chewed or taken with a small amount of water. No special measures, such as stopping meals or using a laxative, are necessary (applies to tablets and chewable tablets). Perform an examination 3 weeks after treatment; if treatment has not been successful, a second course may be given as appropriate.

Child dose

Children aged 24 months and older 1) Pinworm: Take 400 mg of albendazole once daily. To achieve eradication, take another 400 mg dose of this medicine once, 7 days later. 2) Ascaris, hookworm, whipworm, and American hookworm: Take a single 400 mg dose of this medicine. 3) Strongyloides with other parasites (tapeworms) and severe mixed infections: Take 400 mg of this medicine once daily for 3 days.

This drug contains the artificial sweetener aspartame, which breaks down into phenylalanine in the body. Therefore, patients with the genetic disorder phenylketonuria should not take this medication. Daily intake of aspartame should be managed to not exceed the recommended limit by WHO, and for adults weighing 60kg, care should be taken not to exceed 2.4g per day. People who have hypersensitivity to this medicine or are allergic to its components should not take it. It is also safer for pregnant women, women who may become pregnant, nursing mothers, and children under 2 years of age to avoid using this medication. Additionally, as this medication contains lactose, individuals with lactose intolerance or related genetic disorders should avoid taking it. While taking this medication, certain drugs should not be taken together. For example, theophylline may interfere with the metabolism of this medication, and cimetidine, praziquantel, and dexamethasone may increase the concentration of this medication in the blood. Conversely, ritonavir, phenytoin, carbamazepine, and phenobarbital may decrease the blood concentration of this medication; therefore, their concurrent use should be avoided. Patients with liver or kidney dysfunction should consult a doctor or pharmacist before taking this medication. This medication contains the dye Yellow No. 5, so those with allergy or hypersensitivity to this substance should also be cautious. If severe rashes or red spots develop on the skin, or symptoms such as nausea, vomiting, abdominal pain, headache, or dizziness occur while taking this medication, it is necessary to stop taking it immediately and consult a healthcare professional. Rarely, allergic reactions such as fever, rash, and itching may occur, and temporary hair loss may also happen. Women who may become pregnant should confirm their pregnancy status before taking this medication, and it is safer not to use this medication in early pregnancy. Animal studies have reported harm to the fetus; thus, effective contraception should be used during the treatment period and for 3 days after administration. During the use of this medication, the white blood cell count may decrease or liver function test results may increase, so regular testing may be required. In cases of overdose, symptomatic treatment such as gastric lavage should be provided. Patients receiving treatment for intracranial parasites may develop seizures or neurological symptoms due to inflammatory responses; if these symptoms appear, immediate consultation with healthcare providers is needed. This medication should be stored out of reach of children, away from direct sunlight, and in a dry, cool place. Additionally, to prevent misuse or abuse, it is advised not to transfer it to another container.

mucous membrane syndrome, erythema multiforme, nausea, vomiting, heartburn, diarrhea, upper abdominal or abdominal pain, headache, dizziness, fever, generalized erythema, rash, itching, urticaria, reversible alopecia, reversible leukopenia, mild to moderate increase in liver enzyme levels, pancytopenia, seizures, increased intracranial pressure, minor symptoms

Drug interactions

This medication should not be taken together with theophylline, cimetidine, praziquantel, dexamethasone, ritonavir, phenytoin, carbamazepine, or phenobarbital.

This medication should be stored in a sealed container to prevent exposure to air or moisture. Additionally, it is best kept at room temperature between 1 to 30 degrees Celsius. Proper storage will maintain the effectiveness of the medication.

Appearance

Light orange oblong film-coated tablet

Package unit

2 tablets/PTP, 6 tablets/PTP